Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

editorial

. 2021 Feb 4;13(4):609. doi: 10.3390/cancers13040609

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

The Molecular Tumor Board (MTB) at European Institute of Oncology: the way to precision medicine. The MTB plays a pivotal role to integrate patient’s clinico-pathological features with tumor molecular data derived from comprehensive genomic profiling, taking advantage of artificial intelligence systems. The main goal is to offer to patient’s physician recommendations regarding the best—patient-tailored—therapeutic options. ^# Comprehensive genomic profiling performed with Oncomine Comprehensive Assay v.3 (Thermo Fisher Scientific, Waltham, MA, USA) or FoundationOne CDX (Foundation medicine—Roche) [31]. ^## Artificial intelligence support: Navify (Roche Diagnostics). * MTB: Molecular Tumor Board. Multidisciplinary team of specialists including oncologists, surgeons, pathologists, biologists, bioinformatics experts, geneticists, basic and translational scientists, radiologists. ** Diagnostic exams including radiologic exam, re-biopsy, histopathological revision or additional molecular tests.